Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethyl-EPA for Tardive Dyskinesia in Schizophrenia
NCT00114595Phase 4Completed
- Sponsor
- Stellenbosch University
- Start
- Apr 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Epadel in tardive dyskinesia (TD), sponsored by Stellenbosch University. Started Apr 2003; status: completed.
02
Drugs
Epadel
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT00114595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00114595.